TE

Teva

- NYSE:TEVA
Last Updated 2024-04-19

Indeed Snapshot

Track Teva reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 29th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1353 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 205.00 MEDIUM 209.00 FAVORABLE Aug 29th, 2022 02:18PM Aug 29th, 2022 02:18PM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 28th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1353 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 205.00 MEDIUM 209.00 FAVORABLE Aug 28th, 2022 07:54AM Aug 28th, 2022 07:54AM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 27th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1353 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 205.00 MEDIUM 209.00 FAVORABLE Aug 27th, 2022 06:54AM Aug 27th, 2022 06:54AM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 25th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 67.0 70.0 329.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 205.00 MEDIUM 209.00 FAVORABLE Aug 25th, 2022 11:16AM Aug 25th, 2022 11:16AM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 23rd, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 205.00 MEDIUM 209.00 FAVORABLE Aug 23rd, 2022 01:08PM Aug 23rd, 2022 01:08PM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 21st, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 204.00 MEDIUM 209.00 FAVORABLE Aug 21st, 2022 02:55PM Aug 21st, 2022 02:55PM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 20th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 204.00 MEDIUM 209.00 FAVORABLE Aug 20th, 2022 04:34PM Aug 20th, 2022 04:34PM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 19th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 63.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 329.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 204.00 MEDIUM 209.00 FAVORABLE Aug 19th, 2022 02:53PM Aug 19th, 2022 02:53PM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 18th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 64.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 328.0 1351 1400 3.40 3.90 3.00 3.20 3.60 185.00 About two weeks 204.00 MEDIUM 209.00 FAVORABLE Aug 18th, 2022 07:37AM Aug 18th, 2022 07:37AM Teva Health Care Pharmaceuticals & Biotechnology
nyse:teva https://www.indeed.com/cmp/teva-pharmaceuticals Aug 17th, 2022 12:00AM Open Teva Pharmaceuticals Pharmaceutical & Biotechnology Teva Pharmaceutical Industries Ltd. is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions to millions of patients every day. Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, as well as a strong portfolio of respiratory products. Teva integrates its generics and specialty capabilities in its global research and development division to create new ways of addressing unmet patient needs by combining drug development capabilities with devices, services and technologies. With over 43,000 employees in 60 countries worldwide, Teva's net revenues in 2014 amounted to $20.3 billion. For more information, visit www.tevapharm.com. Mission: Our reach is global. Our strategy and leadership are promising and powerful. Our commitment to patients is in the hearts of our employees around the world. Our affordable generic drugs as well as innovative and specialty medicines improve the lives of millions of people each day. Our comprehensive portfolio, combined with our rich, yet focused pipeline and specialty R&D efforts, offer immense promise for Teva, our valued employees, and the patients around the world who depend on our medicines. RRv1_OVER_10B Petah Tikva, IS Kåre Schultz 3.70 70.0 66.0 68.0 66.0 64.0 62.0 59.0 68.0 60.0 62.0 62.0 67.0 70.0 328.0 1351 1400 3.40 3.90 3.00 3.20 3.60 183.00 About two weeks 201.00 MEDIUM 209.00 FAVORABLE Aug 17th, 2022 12:15PM Aug 17th, 2022 12:15PM Teva Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.